| Ms Maeve Riane Tobin, PA-C | |
|
333 School St Ste 112a, Pawtucket, RI 02860-5336 | |
| (401) 728-6990 | |
| Not Available |
| Full Name | Ms Maeve Riane Tobin |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 333 School St Ste 112a, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689153454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | PA01075 (Rhode Island) | Secondary |
| 363A00000X | Physician Assistant | PA01075 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David S Pomerantz Md Inc | 5890725881 | 8 |
| Northeast Dermatology Associates Pc | 3072403799 | 76 |
News Archive
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Nerve mapping technology allows surgeons to determine whether surgery has been effective for relieving pressure from compressed nerves, which often function poorly and cause sciatica or pain and weakness in muscles supplied by the nerve.
A University of Houston pharmacological researcher believes that prescribing the drug Metformin for children and teens as soon as they are diagnosed with mental illnesses, like bipolar disorder and schizophrenia, may save them from gaining an enormous amount of weight.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A computer-based tool could help GPs to speed up the diagnosis and treatment of patients suffering from two of the most common forms of cancer, potentially saving thousands of lives every year.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maeve Riane Tobin, PA-C 140 Courtland St Apt 1r, Providence, RI 02909-1429 Ph: (978) 994-7175 | Ms Maeve Riane Tobin, PA-C 333 School St Ste 112a, Pawtucket, RI 02860-5336 Ph: (401) 728-6990 |
News Archive
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Nerve mapping technology allows surgeons to determine whether surgery has been effective for relieving pressure from compressed nerves, which often function poorly and cause sciatica or pain and weakness in muscles supplied by the nerve.
A University of Houston pharmacological researcher believes that prescribing the drug Metformin for children and teens as soon as they are diagnosed with mental illnesses, like bipolar disorder and schizophrenia, may save them from gaining an enormous amount of weight.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A computer-based tool could help GPs to speed up the diagnosis and treatment of patients suffering from two of the most common forms of cancer, potentially saving thousands of lives every year.
› Verified 8 days ago